Pfizer
Sasha Giacoppo has a diverse work experience in various companies and roles. Most recently, Sasha worked at Pfizer as a Senior Director and Design Team Lead. Prior to that, Sasha served as the Head of Product Design at Visible Alpha, where they focused on transforming the product design discipline to enhance business success. Sasha also held the position of Senior Director of Experience Strategy + Design at Isobar, leading various customer experience strategy and digital transformation projects. Sasha founded Cheqit App, where they developed a financial wellness and budgeting product. Before that, Sasha worked at EY as a Senior Manager, leading digital transformation programs and growing the design team. Sasha also served as Director of Experience Strategy + UX Design at Capco Digital, driving the growth of the UX and innovation design practice. In addition, Sasha created the JetLag Genie App and worked as a UX Design Director at AKQA, a UX Lead at Fluid, and a UX Lead at Lot18.
Sasha Giacoppo obtained a Bachelor of Science degree in Psychology from Penn State University in 1997. In 2002, Giacoppo completed a Master of Arts degree in Human-Computer Interaction (HCI) at The Catholic University of America. Later, Giacoppo pursued a Doctor of Philosophy (PhD) in Administration, Leadership, & Technology at New York University, which was completed in 2007. Additionally, at New York University, Giacoppo obtained a Doctor of Philosophy (PhD) degree with a focus on Educational/Instructional Technology during the same period (2003-2007).
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.